Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

The world's most comprehensive cannabis strain directory, backed by scientific research.

Explore

Strain Directory Indica Strains Sativa Strains Hybrid Strains Breeders

Research

Research Database Medical Conditions Pain Relief Anxiety Insomnia

Tools

Strain Comparator Strain Explorer Blog API

© 2026 BudProfiles. For informational and educational purposes only.

Privacy Policy Terms of Service Disclaimer

11,121 strains · 12,304 studies · 268 breeders

Best Cannabis Strains for Epilepsy - Dravet Syndrome — 0 Strains, 0 Studies | BudProfiles

Home

Conditions

Epilepsy - Dravet Syndrome

Cannabis & Epilepsy - Dravet Syndrome

Explore 0 strains and 0 scientific studies related to Epilepsy - Dravet Syndrome.

0

Strains

0

Studies

16

Positive Studies

85%

Evidence Score

Research Evidence

16

Positive (80.0%)

1

Negative (5.0%)

3

Inconclusive (15.0%)

Scientific Studies

The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials

2024·Clinical Trial

Placebo response in patients with Dravet syndrome: Post-hoc analysis of two clinical trials

2024·Clinical Trial

Dravet syndrome seizure frequency and clustering: Placebo-treated patients in clinical trials

2024·Clinical Trial

Could cannabinoids provide a new hope for ovarian cancer patients?

2023·Review/Other

A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy

2023·Review/Other

Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

2023·Double Blind Clinical Trial

Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study

2023·Review/Other

Use of non-medical cannabis in epilepsy: A scoping review

2023·Review/Other

Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance

2023·Review/Other

Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

2023·Review/Other

Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis

2023·Meta-analysis -

Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

2023·Review/Other

Establishment of a point of departure for CBD hepatotoxicity employing human HepaRG spheroids

2023·Review/Other

Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

2023·Review/Other

Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

2023·Review/Other

Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap

2022·Review/Other

Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

2022·Review/Other

Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex

2022·Review/Other

Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)

2022·Clinical Trial

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

2022·Meta-analysis -